Julie M. Clary MD MBA
Preventive Cardiology
Vice Chair of Clinical Affairs for the Department of Medicine Associate Professor of Clinical Medicine (Cardiology) Indiana University School of Medicine
Join to view full profile
1801 N Senate BlvdSte 4000Indianapolis, IN 46202
Phone+1 317-962-0500
Dr. Clary is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Julie Clary, MD, is a cardiologist based in Indianapolis, IN, specializing in preventive cardiology. She completed her medical education, residency in Internal Medicine, and fellowship in Cardiovascular Disease at Indiana University School of Medicine and subsequently joined the faculty in 2015. Currently, she is an Associate Professor of Clinical Medicine and Vice Chair for Clinical Affairs for the Department of Medicine at IU. Dr. Clary's expertise includes inherited cholesterol disorders, advanced lipidology, and preventive cardiology, as well as organizational administration. Her research contributions include multiple publications, notably on topics like antithrombotic therapy complications, in-hospital mortality prediction in coronary interventions, and clinic efficiency using LEAN Six Sigma techniques.
Education & Training
Indiana University School of MedicineFellowship, Cardiovascular Disease, 2012 - 2015- Indiana University School of MedicineResidency, Internal Medicine, 2009 - 2012
- Indiana University School of MedicineClass of 2009
Certifications & Licensure
IN State Medical License 2010 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification FirstNet (CQM), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2016-2017
Publications & Presentations
PubMed
- Rethinking familial hypercholesterolemia screening: Quantifying missed diagnoses at the intersection of genetic testing and lipoprotein(a).Emma Delaney, Victor Huerta, Lindsey R Helvaty, Julie M Clary, Benjamin M Helm
American Journal of Preventive Cardiology. 2026-10-01 - From identification to implementation: A narrative review of strategies to close the implementation gap in patients with familial hypercholesterolemia.Abhilash Suresh, Sai Sripad Kodukula, Shoshana Bardach, Allison W Peng, Francoise A Marvel
Journal of Clinical Lipidology. 2026-08-01 - Moving beyond clinical risk factors for diagnosis: The necessity of systematic Lp(a) measurement and familial hypercholesterolemia genetic testing.Benjamin M Helm, Victor Huerta, Julie M Clary
Journal of Clinical Lipidology. 2026-07-01
Press Mentions
Health Systems Use AI to Target Patients Who May Have Elevated Lp(A) LevelsAugust 27th, 2025- A Mother's Fight Against the 'Widowmaker': Advocates Raise Awareness for Heart Disease on Wear Red DayFebruary 7th, 2025
- June 2024 NewsletterJune 28th, 2024
Professional Memberships
- Associate Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
